AAOMS Annual Meeting

Conference Coverage

News
Research Summaries
Resources
FDA Alerts Pearls of Wisdom From the Journal
Insights
Commentary Podcasts Q&As Videos
Interactive
Polls Quizzes Slideshows
Events & Education

FDA Alerts

Sun Exposure
Sun Exposure
Active Ingredients in Sunscreen Exceed FDA Absorption Limits
05/09/2019
Several common active ingredients found in sunscreens exceed the maximal thresholds for systemic absorption established by the FDA, according to a new study.
05/09/2019
Immunizations
Immunizations
FDA Approves First Dengue Vaccine in the US
05/03/2019
The FDA has approved the first vaccine approved in the US for the prevention of dengue disease caused by all 4 serotypes of dengue virus in patients aged 9 through 16 years with laboratory-confirmed...
05/03/2019
Immunizations
Immunizations
FDA Approves First Dengue Vaccine in the US
05/03/2019
The FDA has approved the first vaccine approved in the US for the prevention of dengue disease caused by all 4 serotypes of dengue virus in patients aged 9 through 16 years with laboratory-confirmed...
05/03/2019
Immunizations
Immunizations
FDA Approves First Dengue Vaccine in the US
05/03/2019
The FDA has approved the first vaccine approved in the US for the prevention of dengue disease caused by all 4 serotypes of dengue virus in patients aged 9 through 16 years with laboratory-confirmed...
05/03/2019
Hepatitis C
Hepatitis C
FDA Approves New Option For Hep C in Children
05/02/2019
The FDA has approved a new option for the treatment of all 6 genotypes of hepatitis C virus in children aged 12 to 17 years.
05/02/2019
FDA
FDA
FDA Approves First Treatment for Pediatric SLE
04/29/2019
After the clinical trial showed positive results, the first treatment option for children with systemic lupus erythematosus has been approved.
04/29/2019
FDA
FDA
FDA Approves First Treatment for Pediatric SLE
04/29/2019
After the clinical trial showed positive results, the first treatment option for children with systemic lupus erythematosus has been approved.
04/29/2019
FDA
FDA
FDA Approves First Treatment for Pediatric SLE
04/29/2019
After the clinical trial showed positive results, the first treatment option for children with systemic lupus erythematosus has been approved.
04/29/2019
Cardiology
Cardiology
FDA Expands PCSK9 Inhibitor Indication
04/29/2019
The FDA has expanded the indication of a proprotein convertase subtilisin/kexin type 9 inhibitor to include the reduction of risk for myocardial infarction, stroke, and unstable angina requiring...
04/29/2019
Autoimmune diseases
Autoimmune diseases
FDA Approves Enbrel Biosimilar
04/26/2019
The FDA has approved a second biosimilar to etanercept for the treatment of various autoimmune conditions.
04/26/2019